Ishihara Sangyo Kaisha,Ltd.

Tokyo Stock Exchange 4028.T

Ishihara Sangyo Kaisha,Ltd. EBITDA Margin for the year ending March 31, 2024: 11.16%

Ishihara Sangyo Kaisha,Ltd. EBITDA Margin is 11.16% for the year ending March 31, 2024, a 4.85% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Ishihara Sangyo Kaisha,Ltd. EBITDA Margin for the year ending March 31, 2023 was 10.64%, a -27.17% change year over year.
Ishihara Sangyo Kaisha,Ltd. EBITDA Margin for the year ending March 31, 2022 was 14.61%, a 39.19% change year over year.
Ishihara Sangyo Kaisha,Ltd. EBITDA Margin for the year ending March 31, 2021 was 10.50%, a -3.94% change year over year.
Ishihara Sangyo Kaisha,Ltd. EBITDA Margin for the year ending March 31, 2020 was 10.93%, a -27.32% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Tokyo Stock Exchange: 4028.T

Ishihara Sangyo Kaisha,Ltd.

CEO	Mr. Kenichi Tanaka
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	3-15 Edobori 1-chome
Employees	1,813
Sector	Materials
Industries Chemicals & Advanced Materials Petrochemicals Pharmaceuticals

Description

Ishihara Sangyo Kaisha, Ltd. engages in the manufacture and sale of organic and inorganic chemicals in Japan, Asia, the United States, Europe, and internationally. The company offers titanium dioxide (TiO2) products under the TIPAQUE trade name, which includes white pigments for applications in paints, inks, plastics, paper, and other products; yellow pigments; and functional materials, such as ultrafine TiO2, ultrafine ZnO, electro-conductive materials, photocatalytic TiO2, high purity TiO2, titanium tetrachride, TiO2 for catalytic use, acicular type TiO2, glass coating, and battery materials. In addition, it offers matting agents; heat shield materials; agrochemicals, including herbicides, fungicides, insecticides, and nematicides; animal healthcare products; pharmaceutical reagents; and CF3-Pyridine organic intermediates for use in the pharmaceutical research. Ishihara Sangyo Kaisha, Ltd. was founded in 1920 and is headquartered in Osaka, Japan.

Key trends

Past 5 years